Abbott Upgrading Texas Rx Plant Following GMP Warning Letter

 
• By The Pink Sheet

Abbott is accelerating enhancement of the monitoring system validation program for manufacturing at its Austin, Tex. facility following receipt of an FDA warning letter

More from Archive

More from Pink Sheet